Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Statin therapy after stroke or transient ischemic attack—a new weapon in our secondary stroke prevention arsenal?

Nature Clinical Practice Neurology volume 3, pages 130–131 (2007)Cite this article

boxed-textThe Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355: 549–559

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7–22

  2. Sever PS et al. (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361: 1149–1158

    Article  CAS  Google Scholar 

  3. Goldstein LB et al. (2004) Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. Cerebrovasc Dis 18: 1–2

    Article  Google Scholar 

  4. Amarenco P et al. (2003) Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis 16: 389–395

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. University of California at Los Angeles, Stroke Center and Department of Neurology, 710 Westwood Plaza, Los Angeles, CA 90095, USA ovibes@mednet.ucla.edu

Authors and Affiliations

  1. B Ovbiagele is Assistant Professor of Neurology at the UCLA School of Medicine, Los Angeles, CA, USA.,

    Bruce Ovbiagele

Authors
  1. Bruce Ovbiagele
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ovbiagele, B. Statin therapy after stroke or transient ischemic attack—a new weapon in our secondary stroke prevention arsenal?. Nat Rev Neurol 3, 130–131 (2007). https://doi.org/10.1038/ncpneuro0399

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0399

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing